Eloxx Pharmaceuticals (ELOX) Return on Equity [ROE] (2011 - 2026)
Eloxx Pharmaceuticals' Return on Equity [ROE] was -56.67% in Q2 2026.
Powered by 
Analysis
Eloxx Pharmaceuticals (ELOX) Return on Equity [ROE] (2011 - 2026) Analysis & Trends
For FY2022, Return on Equity [ROE] at Eloxx Pharmaceuticals came in at -582.48%, down 177.68 percentage points from FY2021.
- Return on Equity [ROE] has now declined for three consecutive years, with a five-year change of -391.64 percentage points (FY2017 to FY2022).
- In earlier years, Return on Equity [ROE] was -404.80% in FY2021 (-255.89 pp), -148.90% in FY2020 (-20.31 pp), -128.59% in FY2019 (+18.24 pp) and -146.83% in FY2018 (+44.01 pp).
- The Q2 2026 figure marks the highest quarterly Return on Equity [ROE] in data going back to Q4 2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,133.17 Bn | 1,101.76 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 634.79 Bn | 554.65 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 506.40 Bn | 479.51 Bn | 12.70 Bn | - |
| 4 | Merck | 357.93 Bn | 312.31 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 292.69 Bn | 256.68 Bn | 11.24 Bn | 31.52% |
| 6 | Astrazeneca | 265.19 Bn | 238.87 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 238.22 Bn | 193.61 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 195.23 Bn | 169.43 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 171.11 Bn | 117.76 Bn | 10.94 Bn | 4.97% |
| 10 | Eloxx Pharmaceuticals | 87.44 Mn | 13.76 Mn | - | -56.67% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -56.67% |
| Mar 31, 2023 | -1,012.21% |
| Jun 30, 2022 | -648.39% |
| Mar 31, 2022 | -406.32% |
| Dec 31, 2021 | -239.39% |
| Sep 30, 2021 | -164.14% |
| Jun 30, 2021 | -260.42% |
| Mar 31, 2021 | -435.89% |
| Dec 31, 2020 | -261.71% |
| Sep 30, 2020 | -217.67% |
| Jun 30, 2020 | -192.18% |
| Mar 31, 2020 | -164.29% |
| Dec 31, 2019 | -121.52% |
| Sep 30, 2019 | -103.89% |
| Jun 30, 2019 | -113.35% |
| Mar 31, 2019 | -129.56% |
| Dec 31, 2018 | -99.63% |
| Sep 30, 2018 | -61.76% |
| Jun 30, 2018 | -72.01% |
| Mar 31, 2018 | -86.63% |
API Access
Eloxx Pharmaceuticals Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ELOX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "ELOX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ELOX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();